iLet Bionic Pancreas Insulin Only (REF BB1003)Recalls & reported problems
Beta Bionics, Inc. · iLet Bionic Pancreas (Government Starter Kit) · Class 2
All models of iLet Bionic Pancreas (4)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
Quick summary
This Beta Bionics iLet Bionic Pancreas insulin system appears in 9,429 adverse event reports, including 2 deaths and 1,526 injuries, and all of them fall in the last 12 months. The reports mostly describe blood sugar readings that run too high or too low, insulin cartridges that will not seat or that leak, and chargers or pumps that fail to charge or wake. No recalls name this device.
AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.
- Adverse event reports
- 9,393
- Deaths reported
- 2
- Injuries reported
- 1,544
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 9,393 adverse event reports that list this exact device (DI 00850050080190), received between Dec 4, 2025 and Sep 30, 2026 — classified as 2 deaths, 1,544 injuries, 7,847 malfunctions.
The most frequently reported specific device problem is “Insufficient Device Problem Information” (3,422 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Insufficient Device Problem Information3,422
- Improper or Incorrect Procedure or Method1,487
- Intermittent Communication Failure883
- Fracture855
- Key or Button Unresponsive/not Working522
- Failure to Infuse365
- Charging Problem247
- Obstruction of Flow237
Patient problems
- Hyperglycemia4,185
- No Clinical Signs, Symptoms or Conditions3,762
- Hypoglycemia2,008
- Insufficient Information185
- Dizziness147
- Shaking/Tremors127
- Headache123
- Nausea121
Recent adverse event reports
The 25 most recent of 9,393 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 30, 2026Insufficient Device Problem Information
Patient problems: Hyperglycemia
MAUDE report 50954908 ↗InjurySep 30, 2026Obstruction of Flow
Patient problems: Hyperglycemia
MAUDE report 50954783 ↗MalfunctionSep 30, 2026Improper or Incorrect Procedure or Method
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50954513 ↗MalfunctionSep 30, 2026Improper or Incorrect Procedure or Method
Patient problems: Hyperglycemia
MAUDE report 50954147 ↗MalfunctionSep 30, 2026Intermittent Communication Failure
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50953505 ↗MalfunctionSep 30, 2026Intermittent Communication Failure
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50953436 ↗MalfunctionSep 30, 2026Obstruction of Flow
Patient problems: Hyperglycemia
MAUDE report 50953412 ↗MalfunctionSep 30, 2026Unexpected Shutdown
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50952214 ↗MalfunctionSep 30, 2026Premature Discharge of Battery
It was reported that an iLet insulin pump experienced rapid battery depletion after charging to full, with the battery dropping by roughly one-third during a meal announcement and repeating over multiple days, consistent with a premature battery discharge involving the battery component. Symptoms included hyperglycemia with a highest reported blood glucose of 400 mg/dL. Outcomes included a missed dose and a delay to therapy. Investigation included interviews and analysis of information provided by the user and engineering logs. Investigation of this case revealed an energy storage system problem consistent with premature discharge of the battery component. It was concluded, based on previously established findings for similar reports, that the cause was traced to component failure.
Patient problems: Hyperglycemia
MAUDE report 50952207 ↗MalfunctionSep 30, 2026Intermittent Communication Failure
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50952106 ↗InjurySep 30, 2026Insufficient Device Problem Information
Patient problems: Dizziness; Hypoglycemia
MAUDE report 50952063 ↗MalfunctionSep 30, 2026Fracture
It was reported that the iLet pump touchscreen was cracked when the device, placed in a box during a move, collided with other items, resulting in a fractured touchscreen and an unusable screen on the pump. Symptoms included no clinical signs, symptoms, or conditions. Outcomes included no health consequences or impact. Investigation included communication with the user and analysis of information provided by the user. Investigation of this case revealed a stress-related problem associated with a fractured touchscreen component. It was concluded, based on previously established findings for similar reports, that the cause was traced to user handling.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50952052 ↗MalfunctionSep 30, 2026Premature Discharge of Battery
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50952010 ↗MalfunctionSep 30, 2026Obstruction of Flow
Patient problems: Hyperglycemia
MAUDE report 50950053 ↗MalfunctionSep 30, 2026Leak/Splash
It was reported that the user experienced leaking cartridges during a supply change, with insulin leaking inside the iLet during the press and hold step and filling the cartridge chamber, consistent with a device leak/splash associated with the reservoir component. No clinical signs, symptoms, or conditions reported. Outcomes included no health consequences or impact. Investigation included communication with the user and analysis of information provided by the user. Investigation of this case revealed leakage consistent with a seal issue, aligning with a leak/splash event involving the reservoir component. It was concluded, based on previously established findings for similar reports, that the cause was traced to component failure.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50949964 ↗MalfunctionSep 30, 2026Improper or Incorrect Procedure or Method
Patient problems: Hyperglycemia
MAUDE report 50949192 ↗InjurySep 30, 2026Improper or Incorrect Procedure or Method
It was reported that the user¿s Dexcom G7 expired and the user applied a Dexcom G6 continuous glucose monitor (CGM) that was paired to the phone but not to the iLet, resulting in an extended time without CGM data on the pump and subsequent hyperglycemia; the user later entered the pairing code and successfully paired the G6 to the iLet after education on the pairing process and expected pairing time. Symptoms included hyperglycemia with a peak glucose of 502 mg/dL and associated polydipsia. Outcomes included a delay to treatment or therapy during the absence of CGM data. Investigation included communication with the user and analysis of information provided by the user. Investigation of this case revealed no device problem and identified a usage problem, specifically an improper or incorrect procedure in not following pairing instructions; no device component was applicable. It was concluded, based on previously established findings for similar reports, that the cause was failure to follow instructions and an unintended use error that contributed to the event.
Patient problems: Hyperglycemia; Polydipsia
MAUDE report 50948275 ↗MalfunctionSep 30, 2026Insufficient Device Problem Information
Patient problems: Hyperglycemia
MAUDE report 50946451 ↗MalfunctionSep 30, 2026Obstruction of Flow
It was reported that the user experienced repeated occlusion alerts while using the infusion set and associated disposables, with alerts recurring despite multiple full supply changes and no observed bent cannulas, kinked tubing, or air bubbles; at one point the user disconnected and administered manual injections, then later resumed pump delivery after priming the tubing per troubleshooting. Symptoms included an interruption of insulin delivery consistent with an occlusion event without medical intervention. Outcomes included temporary reliance on manual injections with subsequent restoration of pump delivery after troubleshooting and supply changes, without hospitalization reported. Investigation included guided troubleshooting and education, including disconnection, tubing fill, and resumption of insulin delivery. Investigation of this case revealed an occlusion consistent with flow restriction in the disposable pathway, unresolved until supply change and line priming, with no confirmed hardware malfunction noted. It was concluded, based on previously established findings for similar reports, that the cause was user technique and disposable-related flow obstruction.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50945935 ↗InjurySep 30, 2026Insufficient Device Problem Information
It was reported that the patient experienced hypoglycemia with a lowest CGM reading of 60 following a period of hyperglycemia, felt lightheaded and confused/disoriented, and treated the low with two glasses of orange juice per healthcare provider guidance; the patient uses a G7 CGM and expressed confusion regarding pump use and differing instructions, and the cause of the event was unclear. Symptoms included hypoglycemia, confusion/disorientation, and dizziness. Outcomes included an unexpected medical intervention in the form of oral glucose and the event was characterized as a serious injury/illness/impairment. Investigation included communication/interviews and analysis of information provided by the user. Investigation of this case revealed no findings available, with insufficient information for a device problem or component determination. It was concluded, based on previously established findings for similar reports, that the cause was not established. If the device is returned, a physical evaluation will be performed, and a supplemental will be submitted.
Patient problems: Confusion/ Disorientation; Dizziness; Hypoglycemia
MAUDE report 50942416 ↗MalfunctionSep 30, 2026Insufficient Device Problem Information
It was reported that a user of the iLet with Dexcom G7 experienced a high continuous glucose reading up to 195 mg/dL for about one hour while using a cartridge-driven infusion set on the stomach; the user attributed the rise to drinking coffee, had no symptoms, lacked a glucometer confirmation, and was trending down by the end of the call. Symptoms included hyperglycemia. Outcomes included no health consequences or impact. Investigation included communication with the user and analysis of information provided. Investigation of this case revealed no findings available, with insufficient information regarding a device problem or component involvement. It was concluded, based on previously established findings for similar reports, that the cause was not established. If the device is returned, a physical evaluation will be performed, and a supplemental will be submitted.
Patient problems: Hyperglycemia
MAUDE report 50941846 ↗MalfunctionSep 30, 2026Insufficient Device Problem Information
Patient problems: Hyperglycemia; Malaise
MAUDE report 50941544 ↗MalfunctionSep 30, 2026Leak/Splash
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50941533 ↗MalfunctionSep 29, 2026Intermittent Communication Failure
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50940799 ↗InjurySep 29, 2026Improper or Incorrect Procedure or Method
Patient problems: Hyperglycemia
MAUDE report 50939168 ↗
Other Interoperable Automated Glycemic Controller devices
- iLet Bionic Pancreas Insulin OnlyBeta Bionics, Inc. · Interoperable Automated Glycemic Controller5 deaths5,718 reports
- t:slim X2 Insulin Pump with Control-IQ 1005012Tandem Diabetes Care, Inc. · Interoperable Automated Glycemic Controller1 recall4,129 reports
- iLet Bionic Pancreas Insulin OnlyBeta Bionics, Inc. · Interoperable Automated Glycemic Controller1 death1,822 reports
- twiist DKPI-21073-007Sequel Med Tech, LLC · Interoperable Automated Glycemic Controller148 reports
- twiist DKPI-11073-001Sequel Med Tech, LLC · Interoperable Automated Glycemic Controller29 reports
- iLet Starter Kit - Contact Detach Insulin OnlyBeta Bionics, Inc. · Interoperable Automated Glycemic Controller3 reports
- iLet Bionic Pancreas Insulin OnlyBeta Bionics, Inc. · Interoperable Automated Glycemic Controller1 report
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page